- Home
- HKIT vs ANVS Comparison
HKIT vs ANVS Comparison
Compare HKIT & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKIT
- ANVS
- Stock Information
- Founded
- HKIT 1996
- ANVS 2008
- Country
- HKIT China
- ANVS United States
- Employees
- HKIT N/A
- ANVS N/A
- Industry
- HKIT Computer Software: Prepackaged Software
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- HKIT Technology
- ANVS Health Care
- Exchange
- HKIT Nasdaq
- ANVS Nasdaq
- Market Cap
- HKIT 35.7M
- ANVS 31.2M
- IPO Year
- HKIT 2023
- ANVS 2020
- Fundamental
- Price
- HKIT $1.23
- ANVS $1.34
- Analyst Decision
- HKIT
- ANVS Strong Buy
- Analyst Count
- HKIT 0
- ANVS 5
- Target Price
- HKIT N/A
- ANVS $37.00
- AVG Volume (30 Days)
- HKIT 15.8K
- ANVS 261.8K
- Earning Date
- HKIT 04-15-2025
- ANVS 05-12-2025
- Dividend Yield
- HKIT N/A
- ANVS N/A
- EPS Growth
- HKIT N/A
- ANVS N/A
- EPS
- HKIT 0.04
- ANVS N/A
- Revenue
- HKIT $3,449,206.00
- ANVS N/A
- Revenue This Year
- HKIT N/A
- ANVS N/A
- Revenue Next Year
- HKIT N/A
- ANVS N/A
- P/E Ratio
- HKIT $33.40
- ANVS N/A
- Revenue Growth
- HKIT N/A
- ANVS N/A
- 52 Week Low
- HKIT $1.00
- ANVS $1.40
- 52 Week High
- HKIT $2.18
- ANVS $20.00
- Technical
- Relative Strength Index (RSI)
- HKIT 41.90
- ANVS 30.68
- Support Level
- HKIT $1.25
- ANVS $1.43
- Resistance Level
- HKIT $1.32
- ANVS $2.07
- Average True Range (ATR)
- HKIT 0.06
- ANVS 0.13
- MACD
- HKIT -0.01
- ANVS 0.02
- Stochastic Oscillator
- HKIT 0.00
- ANVS 0.69
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.